In contrast to multichannel, an omnichannel strategy begins with your customers' needs, not by creating channels. Omnichannel is an experience designed to match a specific HCP profile — or series of profiles — with content that is delivered in successive engagements
At Anthill, we keep a keen eye on digital marketing and sales innovation. Over just the last couple of years, things have continued to change at dizzying speed. There are new centres of innovation established around the world.
While every company is unique – and every brand poses its own specific issues – we know from our clients that there are plenty of shared challenges in pharma too. Some of these are timeless questions like ‘how do I provide a better experience for HCPs?’ which can now be solved in new and better ways.
Approved email can be highly effective – empowering reps with pre-approved content to engage HCPs. And it’s definitely been proving its worth right now with face-to-face HCP meetings being restricted. But it still has to be done right.
We all know how much the pandemic has impacted the industry’s ability to engage with healthcare professionals (HPCs) and the extent to which companies have switched to digital to maintain HCP relationships. What interesting, however, is where those investments were being directed – and how that might change in the future.
Remote detailing, and generally any kind of remote engagement, has been increasing steadily over the last decade. It was clear that it would have a big part to play in pharma sales and marketing in the future. Last year turbocharged that. Now it’s an essential channel – and is growing exponentially.
You’ve likely heard a lot about modular content over the last few years. It’s often described as being the future of content in pharma. But why? What exactly does it give you that traditional content doesn’t?
Many life sciences companies are experiencing the same problem: global brand strategies are often excellent but aren’t having the expected impact. So, what’s happening?
After years getting the platforms in place, companies are now speeding up their innovation to make the most of every opportunity for direct contact with healthcare professionals.
WebSummit gathered founders and CEOs of the world’s biggest technology companies, together with fast-growing startups, innovators and influencers. Here's our key trends.
Those that truly understand the needs and interests of HCPs and the trends in their behavior see increasing returns from personalised and data driven marketing that provide an effective advantage over their competitors.
In our new e-book, we show how you can take your e-detailing content and make it available to HCPs 24/7 – without losing the ‘guided’ experience that makes it so valuable.
If you have ever tried to localise marketing or sales materials – brochures, presentations, whitepapers, etc. – “complexity” might be one word that comes to mind.
In this article we will try to answer the questions of why it is important that pharma build its digital competences on all level of the organisation and how to go about it.
Do you know how to make your eDetailing content available to HCPs 24/7 – without losing the ‘guided’ experience that makes it so valuable?
Digital transformation has been discussed for a decade now, so we’re all aware of the value-potential that digital marketing initiatives can offer us.
Research from Salesforce shows that 75% of consumers expect a consistent experience wherever they engage with brands – be it through social media, mobile, or even in person.
How do you support healthcare professionals while corona virus restrictions are in place? Two solutions that are particularly relevant to pharma right now are ‘remote engagement’ and ‘self-detailing’.
